Loading...

Brenton Rose

Title(s)Assistant Clinical Professor, Radiation Medicine and Applied Science
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Validation of an oncology-specific opioid risk calculator in cancer survivors. Cancer. 2020 Dec 30. Riviere P, Vitzthum LK, Nalawade V, Deka R, Furnish T, Mell LK, Rose BS, Wallace M, Murphy JD. PMID: 33378556.
      View in: PubMed   Mentions:    Fields:    
    2. Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance. JAMA. 2020 11 03; 324(17):1747-1754. Deka R, Courtney PT, Parsons JK, Nelson TJ, Nalawade V, Luterstein E, Cherry DR, Simpson DR, Mundt AJ, Murphy JD, D'Amico AV, Kane CJ, Martinez ME, Rose BS. PMID: 33141207.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Pathologic nodal downstaging in men with clinically involved lymph nodes undergoing radical prostatectomy: Implications for definitive locoregional therapy. Urol Oncol. 2020 Oct 26. Ghali F, Daly WC, Hansen M, Hayn M, Sammon J, Beaule LT, Sarkar R, Murphy J, Kader AK, Derweesh I, Rose B, Ryan ST. PMID: 33121914.
      View in: PubMed   Mentions:    Fields:    
    4. Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration. Cancer. 2021 Feb 01; 127(3):403-411. PMID: 33036065.
      View in: PubMed   Mentions:    Fields:    
    5. Stereotactic body radiotherapy versus conventional/moderate fractionated radiation therapy with androgen deprivation therapy for unfavorable risk prostate cancer. Radiat Oncol. 2020 Sep 15; 15(1):217. Patel SA, Switchenko JM, Fischer-Valuck B, Zhang C, Rose BS, Chen RC, Jani AB, Royce TJ. PMID: 32933541.
      View in: PubMed   Mentions:    Fields:    
    6. Three-tiered Subclassification System of High-risk Prostate Cancer in Men Managed With Radical Prostatectomy: Implications for Treatment Decision-making. Urology. 2020 Nov; 145:197-203. Lamba N, Butler S, Mahal BA, Trinh QD, Rose B, King M, Orio P, Mouw KW, Martin N, Leeman JE, Feng FY, Nguyen PL, Muralidhar V. PMID: 32763323.
      View in: PubMed   Mentions:    Fields:    
    7. Reply to Equal access to health care reduces racial disparities in prostate cancer outcomes and Access and socioeconomic status play an important role in outcomes for African American patients with prostate cancer. Cancer. 2020 Sep 15; 126(18):4258. Riviere PJ, Rose BS. PMID: 32644210.
      View in: PubMed   Mentions:    Fields:    
    8. Evaluation of the Use of Cancer Registry Data for Comparative Effectiveness Research. JAMA Netw Open. 2020 07 01; 3(7):e2011985. Kumar A, Guss ZD, Courtney PT, Nalawade V, Sheridan P, Sarkar RR, Banegas MP, Rose BS, Xu R, Murphy JD. PMID: 32729921.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Predicting Persistent Opioid Use, Abuse, and Toxicity Among Cancer Survivors. J Natl Cancer Inst. 2020 Jul 01; 112(7):720-727. Vitzthum LK, Riviere P, Sheridan P, Nalawade V, Deka R, Furnish T, Mell LK, Rose B, Wallace M, Murphy JD. PMID: 31754696.
      View in: PubMed   Mentions: 1     Fields:    
    10. Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease. Prostate Cancer Prostatic Dis. 2020 Dec; 23(4):689-695. Sarkar RR, Patel SH, Parsons JK, Deka R, Kumar A, Einck JP, Mundt AJ, Kader AK, Kane CJ, Riviere P, McKay R, Murphy JD, Rose BS. PMID: 32513967.
      View in: PubMed   Mentions:    Fields:    
    11. Palliative Radiotherapy Versus Esophageal Stent Placement in the Management of Patients With Metastatic Esophageal Cancer. J Natl Compr Canc Netw. 2020 05; 18(5):569-574. Martin EJ, Bruggeman AR, Nalawade VV, Sarkar RR, Qiao EM, Rose BS, Murphy JD. PMID: 32380466.
      View in: PubMed   Mentions:    Fields:    
    12. African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance. Prostate Cancer Prostatic Dis. 2020 Dec; 23(4):581-588. Deka R, Parsons JK, Simpson DR, Riviere P, Nalawade V, Vitzthum LK, Kader AK, Kane CJ, Rock CS, Murphy JD, Rose BS. PMID: 32327702.
      View in: PubMed   Mentions:    Fields:    
    13. Associations among statins, preventive care, and prostate cancer mortality. Prostate Cancer Prostatic Dis. 2020 09; 23(3):475-485. Kumar A, Riviere P, Luterstein E, Nalawade V, Vitzthum L, Sarkar RR, Bryant AK, Einck JP, Mundt AJ, Murphy JD, Rose BS. PMID: 32029930.
      View in: PubMed   Mentions: 1     Fields:    
    14. Survival of African American and non-Hispanic white men with prostate cancer in an equal-access health care system. Cancer. 2020 04 15; 126(8):1683-1690. Riviere P, Luterstein E, Kumar A, Vitzthum LK, Deka R, Sarkar RR, Bryant AK, Bruggeman A, Einck JP, Murphy JD, Martínez ME, Rose BS. PMID: 31984482.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    15. Combined Androgen Blockade in Localized Prostate Cancer Treated With Definitive Radiation Therapy. J Natl Compr Canc Netw. 2019 12; 17(12):1497-1504. Vitzthum LK, Straka C, Sarkar RR, McKay R, Randall JM, Sandhu A, Murphy JD, Rose BS. PMID: 31805534.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Tobacco smoking and death from prostate cancer in US veterans. Prostate Cancer Prostatic Dis. 2020 06; 23(2):252-259. Riviere P, Kumar A, Luterstein E, Vitzthum LK, Nalawade V, Sarkar RR, Bryant AK, Einck JP, Mundt AJ, Murphy JD, Rose BS. PMID: 31624316.
      View in: PubMed   Mentions:    Fields:    
    17. Association of Treatment With 5a-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults. JAMA Netw Open. 2019 10 02; 2(10):e1913612. Kumar A, Nalawade V, Riviere P, Sarkar RR, Parsons JK, Murphy JD, Rose BS. PMID: 31626312.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. 5a-Reductase Inhibitor Use in Patients With Prostate Cancer-Reply. JAMA Intern Med. 2019 10 01; 179(10):1440-1441. Sarkar RR, Rose BS. PMID: 31589264.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Benefits of Targeted Use of 5a-Reductase Inhibitors in Patients With Prostate Cancer-Reply. JAMA Intern Med. 2019 10 01; 179(10):1442. Sarkar RR, Rose BS. PMID: 31589266.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. A Matched Case-Control Analysis of Clinical Outcomes for Patients With Inflammatory Bowel Disease and Rectal Cancer Treated With Pelvic Radiation Therapy. Int J Radiat Oncol Biol Phys. 2019 12 01; 105(5):994-1004. Mudgway R, Bryant AK, Heide ES, Riviere P, O'Hare C, Rose BS, Murphy JD, Simpson DR. PMID: 31461672.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen Level. J Natl Compr Canc Netw. 2019 08 01; 17(8):941-948. Muralidhar V, Nguyen PL, Mahal BA, Yang DD, Mouw KW, Rose BS, Beard CJ, Efstathiou JA, Martin NE, King MT, Orio PF. PMID: 31390585.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Association of Treatment With 5a-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer. JAMA Intern Med. 2019 06 01; 179(6):812-819. Sarkar RR, Parsons JK, Bryant AK, Ryan ST, Kader AK, McKay RR, D'Amico AV, Nguyen PL, Hulley BJ, Einck JP, Mundt AJ, Kane CJ, Murphy JD, Rose BS. PMID: 31058923.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    23. In Reply to Hurmuz and Ozyigit. Int J Radiat Oncol Biol Phys. 2019 05 01; 104(1):225. Bryant AK, Rose BS. PMID: 30967234.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Stroke and thromboembolic events in men with prostate cancer treated with definitive radiation therapy with or without androgen deprivation therapy. Prostate Cancer Prostatic Dis. 2019 12; 22(4):600-608. Deka R, Simpson DR, Panizzon MS, Hauger RL, Riviere P, Nalawade V, McKay R, Murphy JD, Rose BS. PMID: 30988408.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Claims-Based Approach to Predict Cause-Specific Survival in Men With Prostate Cancer. JCO Clin Cancer Inform. 2019 03; 3:1-7. Riviere P, Tokeshi C, Hou J, Nalawade V, Sarkar R, Paravati AJ, Schiaffino M, Rose B, Xu R, Murphy JD. PMID: 30830794.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy. Cancer. 2019 04 01; 125(7):1070-1080. Deka R, Rose BS, Bryant AK, Sarkar RR, Nalawade V, McKay R, Murphy JD, Simpson DR. PMID: 30748008.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Postoperative radiation and hormonal therapy for men with node-positive prostate cancer: a new standard? BJU Int. 2019 02; 123(2):199-200. Rose BS. PMID: 30656836.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Detecting a Survival Benefit to Dose Escalation. JAMA Oncol. 2019 01 01; 5(1):109-110. Zakeri K, Rose BS, Mell LK. PMID: 30452492.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. Subcastrate Testosterone Nadir and Clinical Outcomes in Intermediate- or High-Risk Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2019 04 01; 103(5):1068-1076. Bryant AK, McKay RR, Kader AK, Parsons JK, Einck JP, Kane CJ, Mundt AJ, Murphy JD, Rose BS. PMID: 30543857.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    30. Association of Androgen Deprivation Therapy With Dementia in Men With Prostate Cancer Who Receive Definitive Radiation Therapy. JAMA Oncol. 2018 11 01; 4(11):1616-1617. Deka R, Simpson DR, Bryant AK, Nalawade V, McKay R, Murphy JD, Rose BS. PMID: 30325986.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    31. Association between Radical Prostatectomy and Survival in Men with Clinically Node-positive Prostate Cancer. Eur Urol Oncol. 2019 09; 2(5):584-588. Sarkar RR, Bryant AK, Parsons JK, Ryan ST, Karim Kader A, Kane CJ, McKay RR, Sandhu A, Murphy JD, Rose BS. PMID: 31411995.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Three-month posttreatment prostate-specific antigen level as a biomarker of treatment response in patients with intermediate-risk or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapy. Cancer. 2018 07 15; 124(14):2939-2947. Bryant AK, D'Amico AV, Nguyen PL, Einck JP, Kane CJ, McKay RR, Simpson DR, Mundt AJ, Murphy JD, Rose BS. PMID: 29727915.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 08 01; 101(5):1188-1193. Bryant AK, Kader AK, McKay RR, Einck JP, Mell LK, Mundt AJ, Kane CJ, Efstathiou JA, Murphy JD, Rose BS. PMID: 29891203.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Who benefits most from early salvage radiation therapy after prostatectomy? Transl Androl Urol. 2018 Mar; 7(Suppl 1):S124-S127. Nath SK, Rose BS, Pugh TJ. PMID: 29644179.
      View in: PubMed   Mentions:
    35. Salvage image guided radiation therapy to the prostate after cryotherapy failure. Adv Radiat Oncol. 2018 Jan-Mar; 3(1):52-56. Hopper AB, Sandhu APS, Parsons JK, Rose B, Einck JP. PMID: 29556580.
      View in: PubMed   Mentions:
    36. Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiation. Pract Radiat Oncol. 2017 Sep - Oct; 7(5):e291-e297. Rose B, Mitra D, Hong TS, Jee KW, Niemierko A, Drapek LN, Blaszkowsky LS, Allen JN, Murphy JE, Clark JW, Ryan DP, Wo JY. PMID: 28462895.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    37. Reply to S. Sorscher. J Clin Oncol. 2017 05 20; 35(15):1746-1747. Rose BS, Winer EP, Mamon HJ. PMID: 28524778.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529. Adv Radiat Oncol. 2017 Apr-Jun; 2(2):110-117. Mitra D, Hong TS, Horick N, Rose B, Drapek LN, Blaszkowsky LS, Allen JN, Kwak EL, Murphy JE, Clark JW, Ryan DP, Cusack JC, Bordeianou LG, Berger DL, Wo JY. PMID: 28740921.
      View in: PubMed   Mentions:
    39. Perils of the Pathologic Complete Response. J Clin Oncol. 2016 11 20; 34(33):3959-3962. Rose BS, Winer EP, Mamon HJ. PMID: 27551115.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    40. Disparities in the Receipt of Local Treatment of Node-positive Prostate Cancer. Clin Genitourin Cancer. 2017 10; 15(5):563-569.e3. Muralidhar V, Mahal BA, Rose BS, Chen YW, Nezolosky MD, Efstathiou JA, Beard CJ, Martin NE, Orio PF, Trinh QD, Choueiri TK, Sweeney CJ, Nguyen PL. PMID: 28462857.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Androgen Deprivation Therapy Use in the Setting of High-dose Radiation Therapy and the Risk of Prostate Cancer-Specific Mortality Stratified by the Extent of Competing Mortality. Int J Radiat Oncol Biol Phys. 2016 11 15; 96(4):778-784. Rose BS, Chen MH, Wu J, Braccioforte MH, Moran BJ, Doseretz DE, Katin MJ, Ross RH, Salenius SA, D'Amico AV. PMID: 27788950.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice? Int J Radiat Oncol Biol Phys. 2016 10 01; 96(2):313-317. Muralidhar V, Rose BS, Chen YW, Nezolosky MD, Nguyen PL. PMID: 27496390.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    43. Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events. J Clin Oncol. 2016 Apr 10; 34(11):1270-7. Carmona R, Zakeri K, Green G, Hwang L, Gulaya S, Xu B, Verma R, Williamson CW, Triplett DP, Rose BS, Shen H, Vaida F, Murphy JD, Mell LK. PMID: 26884579.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    44. Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation. Int J Radiat Oncol Biol Phys. 2016 Mar 15; 94(4):747-54. Rose BS, Jee KW, Niemierko A, Murphy JE, Blaszkowsky LS, Allen JN, Lee LK, Wang Y, Drapek LC, Hong TS, Wo JY. PMID: 26972647.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    45. Effect of lymph node metastasis size on breast cancer-specific and overall survival in women with node-positive breast cancer. Breast Cancer Res Treat. 2015 Jul; 152(1):209-216. Rose BS, Jiang W, Punglia RS. PMID: 26041688.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    46. Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer. Radiother Oncol. 2015 Apr; 115(1):114-9. Zakeri K, Rose BS, D'Amico AV, Jeong JH, Mell LK. PMID: 25857696.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    47. Complications of pelvic radiation in patients treated for gynecologic malignancies. Cancer. 2014 Dec 15; 120(24):3870-83. PMID: 25056522.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    48. Validated competing event model for the stage I-II endometrial cancer population. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):888-98. PMID: 24969798.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    49. Maximum tumor diameter and the risk of prostate-specific antigen recurrence after radical prostatectomy. Clin Genitourin Cancer. 2014 Oct; 12(5):e173-9. Rose BS, Chen MH, Zhang D, Hirsch MS, Richie JP, Chang SL, Hegde JV, Loffredo MJ, D'Amico AV. PMID: 24787967.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    50. On lumping, splitting, and the nosology of clinical trial populations and end points. J Clin Oncol. 2014 Apr 01; 32(10):1089-90. PMID: 24550413.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    51. Clinical practice patterns of lung stereotactic body radiation therapy in the United States: a secondary analysis. Am J Clin Oncol. 2013 Jun; 36(3):269-72. PMID: 22495454.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    52. Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma. J Neurooncol. 2013 Jul; 113(3):467-77. PMID: 23673513.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    53. Outcomes for patients with cervical cancer treated with extended-field intensity-modulated radiation therapy and concurrent cisplatin. Int J Gynecol Cancer. 2013 Jan; 23(1):119-25. PMID: 23262521.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    54. Competing event risk stratification may improve the design and efficiency of clinical trials: secondary analysis of SWOG 8794. Contemp Clin Trials. 2013 Jan; 34(1):74-9. PMID: 23063467.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    55. Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):406-14. PMID: 22687195.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    56. Reporting of cause-specific treatment effects in cancer clinical trials with competing risks: a systematic review. Contemp Clin Trials. 2012 Sep; 33(5):920-4. PMID: 22664646.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    57. Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):e81-6. PMID: 22516388.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    58. Correlation between radiation dose to ¹8F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):1185-91. PMID: 22270171.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    59. Population-based study of competing mortality in head and neck cancer. J Clin Oncol. 2011 Sep 10; 29(26):3503-9. Rose BS, Jeong JH, Nath SK, Lu SM, Mell LK. PMID: 21844503.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    60. Observed magnetic resonance imaging changes in pediatric patients treated with stereotactic radiosurgery for intracranial tumors. Childs Nerv Syst. 2011 Mar; 27(3):399-406. Nath SK, Carmona R, Rose BS, Simpson DR, Russell M, Lawson JD, Mundt AJ, Murphy KT. PMID: 20927529.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    61. A survey of image-guided radiation therapy use in the United States. Cancer. 2010 Aug 15; 116(16):3953-60. Simpson DR, Lawson JD, Nath SK, Rose BS, Mundt AJ, Mell LK. PMID: 20564090.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    62. Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2011 Aug 01; 80(5):1436-45. Hasselle MD, Rose BS, Kochanski JD, Nath SK, Bafana R, Yashar CM, Hasan Y, Roeske JC, Mundt AJ, Mell LK. PMID: 20708346.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    63. Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data. Int J Radiat Oncol Biol Phys. 2010 Nov 01; 78(3):912-9. Liang Y, Messer K, Rose BS, Lewis JH, Jiang SB, Yashar CM, Mundt AJ, Mell LK. PMID: 20472344.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    64. Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):800-7. Rose BS, Aydogan B, Liang Y, Yeginer M, Hasselle MD, Dandekar V, Bafana R, Yashar CM, Mundt AJ, Roeske JC, Mell LK. PMID: 20400238.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCellsPHPublic Health
    65. Utilization of advanced imaging technologies for target delineation in radiation oncology. J Am Coll Radiol. 2009 Dec; 6(12):876-83. Simpson DR, Lawson JD, Nath SK, Rose BS, Mundt AJ, Mell LK. PMID: 19945044.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    66. Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010 Oct 01; 78(2):435-41. Nath SK, Sandhu AP, Rose BS, Simpson DR, Nobiensky PD, Wang JZ, Millard F, Kane CJ, Parsons JK, Mundt AJ. PMID: 19939580.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansPHPublic Health
    67. Recent advances in image-guided radiotherapy for head and neck carcinoma. J Oncol. 2009; 2009:752135. Nath SK, Simpson DR, Rose BS, Sandhu AP. PMID: 19644564.
      View in: PubMed   Mentions:
    Brenton's Networks
    Concepts (212)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (40)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑